TY  - JOUR

T1  - Zometa® is effective and well tolerated in the prevention of skeletal related events secondary to metastatic breast cancer treated with hormonal therapy

JO  - European Journal of Cancer

PY  - 2001/04/01

AU  - Coleman R

AU  - Apffelstaedt J

AU  - Gordon D

AU  - Major P

AU  - Mackey J

AU  - Howell A

AU  - Theriault R

AU  - Yambros Y

AU  - Chen B

AU  - Reitsma D

ED  - 

DO  - DOI: 10.1016/s0959-8049(01)81045-5

PB  - Elsevier BV

VL  - 37

SP  - S152

EP  - S152

Y2  - 2025/10/10

ER  -